degeneration of Sertoli cells and proliferation of Leydig cells at a 1492 mg/kg/day HCA dose (NIHS internal report). On the other h '
ally. This quantity is equivalent to 15 times the general humans dose used for anti-obesity (20 mg/kg/day). It was supposed that this dose or under would have no influence on human testicular function. Although the results obtained on animal tests suggest potent effects on the gonadal systems, hormonal changes associated with long-term oral administration have not been known well. Hence, a pilot study (study I) was carried out to determine the safety of Garcinia extract powder for the endocrinology of humans. In the study I, a dosage of 3000 mg/day HCA was administered to 10 healthy men for 30 days (10) . There were no toxicological changes in anthropometric indices, clinical analysis, or serum testosterone, and no serious subjective symptoms. However, the influences on inhibin B, FSH and other principal sex hormones and on women subjects were not investigated. Inbihib B is produced by Sertoli cells, provides negative feedback on FSH secretion and is considered to be an importan marker of spermatogenesis (11) (12) (13) (14) .
The purpose of this study, then, was to evaluate the safety of Garcinia extract from three points of view: 1) its influences on the principal sex hormones of males, 2) the influence of sex difference, and 3) the influence of long-term excessive administration.
Experimental 1 Samples
Soluble type Garcinia cambogia extract (Garcinia extract powder) containing 60% ( )-HCA was purchased from Nippon Shinyaku Co. (Kyoto, JAPAN). Garcinia tablets contained 185.2 mg Garcinia extract powder (111.1 mg HCA). Placebo tablets were identical in appearance, but Garcinia extract powder had been replaced with cellulose (Avicel, Asahi Chemical, Tokyo, JAPAN) as an inert ingredient. Garcinia tablets and placebo were given in single-blind fashion. Both were taken as nine tablets three times daily 30mins before every meals (27 tablets per day). The total daily dose was 5000 mg Garcinia extract powder (3000 mg/day as HCA).
Subjects and Method
This study was approved by the Institutional Review Board of FANCL Co. and carried out in accordance with the Helsinki Declaration of 1964 (revised in 2000). We explained the purpose, benefit and possible risks of this study to 48 healthy volunteers (24 men and 24 women), who then gave their consent to participate. Exclusion criteria were as follows: those who had a gastroenteric condition (chronic diarrhea, constipation and a stomachache), those with a food allergy and diagnosed diabetes mellitus or cardiovascular disease, and women who were pregnancy or lactation.
The ages of subjects were between 22 and 46 years (mean SD: 30.5 5.9). Smoking, alcohol and menstrual patterns were researched prior to the start of procedures. The study was conducted in single blind design. The test period of the study was 14 weeks, consisting of a 2-week placebo treatment period (-2week to 0week) and a 12-week Garcinia treatment period (0week to 12week). Blood samples were collected from subjects at weeks -2, 0, 4, 8 and 12 between 9:00 to 11:00 after overnight fasting, which began at 21:00 the previous night on. The subjects also underwent complete physical examinations and urinalysis on the same day. Side effects were monitored throughout the study period.
3 Hormone Assay
Inhibin B was measured by a two-site enzymelinked-immunnosorbent assay (ELISA) using a commercial kit (INHIBIN-B ASSAY KIT, OXFORD BIO-INNOVATION Ltd., Oxford, UK). Analysis of serum FSH (follicle stimulating hormone), LH (luteinizing hormone), testosterone (only men) and progesterone (only women) using radio-immunoassay (RIA) were commissioned to the inspection company (SRL Co., Tokyo, JAPAN).
4 Blood Analysis and Urinalysis
Analysis of hematology (WBC, RBC, Hb, hematocrit and platelet), part of the hemobiochemistry (TG, FFA, TC, HDL-cho, LDL-cho, blood urea nitrogen, creatinine, total bilirubin, ketone bodies, Na, K, Cl and insulin) and urinalysis (pH, urobilinogen, bilirubin, ketone, glucose, protein and occult blood) were carried out by the inspection company (SRL Co., Tokyo, 664 JAPAN). Measurement of serum glucose, aspartate aminotransferase (AST), alanine aminotransferase (ALT), g-glutamyltranspeptidase (g-GTP), lactate dehydrogenase and alkaline phosphatase were carried out on the automated analysis system DRI-CHEM 3500 (FUJI FILM Co., Tokyo, JAPAN).
5 Anthropometric Parameters
All anthropometric parameters were measured by trained observers using standardized techniques. Body weight (to nearest 0.1kg), body height (to the nearest 0.1 cm) and body fat ratio (%) were measured by the digital scale BODY FAT ANALYSER (TBF-210 TANI-TA : Tokyo, JAPAN). Circumference measurements to the nearest 0.1 cm were taken with the subjects standing upright. Waist circumference was measured at the umbilical level. Hip circumstance was measured at the level of the widest circumference over the great trochanters.
6 Statistics
Parameters of hematology, hemobiochemistry and body indices were presented as means SD. Differences in the hematology, hemobiochemistry and anthropometric parameters in the placebo treatment period (-2week vs. 0week) and Garcinia treatment period (0week vs. postprandial effects (4,8 and 12week)) were performed by paired t-test. Statistical significance was set at P<0.05 (two-tailed). All analyses were performed with StatView Ver.5.0 for Windows (SAS Institute Inc., Cary, NC, USA).
Results

1 Subjects
A total of 48 volunteers (24 men and 24 women) participated in this study. Their characteristics are shown in Table 1 . In terms of BMI, 39 of the 48 subjects were within normal range (BMI : 18.5 kg/m 2 25.0 kg/m 2 ). Two women were oligomenorrheic (cyclerength 60 :
6 cycles per year). The other 22 women had normal menstrual cycles. A woman withdrew after the placebo treatment period and another woman withdrew before the 8-week inspection because of personal reasons. Although 2 subjects (1man and 1woman) missed an inspect on account of work, they participated in the next inspection. Since the aim of this study was verification of safety, all subjects were included in the statistic analysis.
2 Hormone Levels in Men
As shown in Fig. 1a) , the mean serum inhibin B level at week 12 (186.7 61.6 pg/dL) was higher than the week 0 (162.1 46.2 pg/dL) (P<0.01), and the mean serum FSH level at week 12 (5. 18 2.75 mIU/mL) was higher than week 0 (4.68 2.65 mIU/mL) (P<0.01). But these differences were very slight. No significant differences were observed for serum LH and testosterone levels (Fig. 1b) .
Hormone Levels and Menstrual Cycle
in Women Changes in serum hormone levels in women are shown in Fig. 1c) and Fig. 1d ). Since the menstrual phases (menstrual, follicular and luteal phase) were different at each inspection period, the serum hormone levels varied greatly. However, there was no data that deviated from the reference value. Although the mean serum LH level at weeks 8 and 12 were higher than at week 0, the changes were not statistically significant. No changes were shown in the other parameters. In the 22 women with normal menstrual cycles, no changes in the menstrual cycle were observed.
4 Hematology, Hemobiochemistry and
Urinalysis Results of hematology and hemobiochemistry are shown in Table 2 (men) and Table 3 (women). Although some parameters showed significantly differences at week 12 compared with week 0, the whole of the change was settled into the standard. Each of the serum levels related to liver function, including AST, ALT and g-GTP was higher than week 0, but the correlation between the changes and the Garcinia treatment was not clear. There were no changes in urinalysis parameters (data not shown). Table 4 shows changes of body compositions. During the placebo period, a slight decrease was accepted in body weight (men), body fat ratio (women) and hip circumference (women). In addition, in Garcinia treatment period, an increase of body fat ratio (men) and decrease in waist circumstance both sexes were observed. But these changes were slight or had no clinical significance. There was no subject whose body composition showed a remarkable change.
5 Body Indices
6 Gastro-Intestinal Symptoms and Side
Effects Frequencies of gastro-intestinal symptoms (diarrhea, abdominal pain, distention) were lower in the Garcinia treatment period than in the placebo period (Fig. 2) . In the Garcinia treatment period, headache, common cold, fever, nausea and nosebleed were observed for other symptom as symptoms. No serious adverse effects were reported.
Discussion
In this study, we reviewed the influence of long-term excessive ingestion of Garcinia extract powder (3000 mg/day as HCA, 12 weeks) in healthy men and women. A slight increase of inhibin B and FSH were observed in the men. It is known that inhibin B, a dimeric gonadal glycoprotein, inhibits the pituitary secretion of FSH in a classic feedback loop, while secretion from a Sertoli cell is promoted by FSH (11) (12) (13) 
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Sertoli cell and has an important role in spermatogenesis (14) . In men with oligozoospermia or a spermary obstacle, it has been shown the serum inhibin B concentration is low and FSH concentration is high compared to normal men (15) (16) (17) (18) . These reports strongly suggest that inhibin B may offer a clinically useful serum marker of testicular function such as a spermatogenesis and Sertoli cell function. In this study, the serum inhibin B concentration was changed by administration of Garcinia extract powder. However, it was thought that there was no degenerative change in spermatogenic cells or Sertoli cells since the change in inhibin B tended to increase. Taking into account the interaction between inhibin B and FSH, it was predicted that FSH would decrease if the change in inhibin B was of physiological significance. Serum FSH levels show only a slight increase in this study. In other words, these findings suggest that there is no physiological significance to the change in inhibin B. In the women, there was no influence on the menstrual cycles or hormones, so it seemed that there was no influence on the female generative function. Garcinia dosage (60 mg/kg as HCA) administered in this study was much less than the dosage that induced testicular change in rats (1476 ## mg/kg as HCA). But it seems that it is adequately excessive compared to the curative dose (20 mg/kg as HCA). Moreover, although Garcinia has been used as spice for a long time and as a supplement for several years already, associated disorder in reproductive functioning have not yet been reported. Therefore, it is suggested that there is no influence on spermatogenesis of excessive ingestion in the range generally taken by humans. Similar phenomenons have been known to occur with other foods. For example, a high dose 8-week oral administration of green tea extracts (including high concentrate cathechin) to male rats decreased the weight of the body, testes and prostate, and changed hormone levels such as testosterone and LH (19) . But the usual amount of intake over a long period of time has not induced testicular disorders.
On the other hand, significant changes were observed in some parameters related to liver function, such as AST, ALT and g-GTP, but these were not recognized as clinical problems. In fact, because all the changes were so small or transient, the evidence for causal relationship involving Garcinia is tenuous.
In subjective symptoms, gastroenteric problems were observed more in the placebo ingestion period than in the examination period. The symptoms were believed to be mentally induced from the ingestion of so many tablets (27 per day). This would explain why gastroenteric problems decreased gradually: subjects simply became habituated to the excessive tablet intake. Interestingly, although 3 times the effective dose was taken for 12 weeks, no remarkable reduction of weight, body fat rate, etc. was observed. One reason for these results may be that most of the subjects (37 out of 48) were at of below normal weight. The results did help to disprove the risk of excessive weight loss by Garcinia intake; it was shown that anti-overweight action can be expected only in overweight persons. The latest research has clearly shown that obesity, especially intra-abdominal visceral fat accumulation, is closely correlated with the occurrence of risk factors for arteriosclerotic diseases, such as hypertension, hyperlipemia, and diabetes (20) (21) (22) (23) (24) (25) . Therefore, the dissolution of visceral fat obesity may be important from the viewpoint of preventing lifestyle-related diseases and arteriosclerotic diseases. The effects of ( )-HCA, including the suppression of fatty acid synthesis, lipogenesis and induction of weight loss, has been clarified, and Garcinia is already used widely as a dietly material. In this study, the safety of high-dose long-term ingestion of Garcinia was confirmed. Thereby, it was shown that Garcinia is a useful material for the prevention or the improvement of various lifestyle-related disease accompanying obesity, and in particular, visceral fat obesity.
Conclusion
Slight increases in serum inhibin B and FSH were observed as a result of long-term excessive intake of Garcinia extract powder (3000 mg/day as HCA, 12 weeks) in healthy volunteers, but these would not be expected to affect the reproductive function to any significant degree. In addition, there were no changes in sex hormone levels or menstrual cycles in women. From these findings, the influence of Garcinia on reproductive functioning is not considered to be a problem at curative dose levels. Given the safety and availability of Garcinia, it is expected to be further utilized in treating obesity, which is a clinical problem of modern societies.
